Verdict: Side-by-side breakdown using the Bull Rankings model. GRDN scored 69.8, ADUS scored 74.5 — ADUS leads.
Compare another set
GRDN
Guardian Pharmacy Services, Inc.
Medical Care Facilities · Quality-Growth
69.8
$41.28 · $2.6B
fundamentals as of
Score gap
4.7
ADUS leads
ADUS
Addus HomeCare Corporation
Medical Care Facilities · Quality-Growth
74.5
$114.33 · $2.1B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
CheapestADUS20.0x
Fastest growthADUS+23.2%
Strongest balance sheetADUS0.09
Highest qualityGRDN81 / 100
Largest discount to fair valueADUS-35%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
GRDN
stronger →← stronger
ADUS
81
Qualityreturns · margins · balance sheet
59
87
Growthrevenue & earnings expansion
84
48
Valuevaluation vs sector peers
84
GRDN is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
GRDN
ADUS
$80mC-
FCF
$155mC
+17.9%B+
Rev
+23.2%A-
0.15B+
D/E
0.09B+
40.5xC
P/E
20.0xB+
3.93D
PEG
1.00B+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
GRDN
ADUS
76% above
Price vs fair valuelower is cheaper
35% below
~24%/yr
Growth the price impliesyr-1 FCF growth, fading to 4% · lower = less priced in
~-1%/yr
-50%
1-yr DCF upside
+35%
-43%
5-yr DCF upside
+53%
-32%
10-yr DCF upside
+83%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
GRDN
Why this score
Short track record
ADUS
No notable signals flagged.
The companies
GRDNGuardian Pharmacy Services, Inc.
Medical Care Facilities · $41.28 · beta 0.02
Why now
Medical Care Facilities · market cap $2.6b. 15% off the 52-week high of $48.33. Revenue growing +18%, comfortably above the S&P median. 7 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $49.86 (implying +21% upside).
Moat
ROE 30% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. FCF converts 121% of net income — earnings translate cleanly into cash.
Risk
Trailing P/E 40x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. Net margin 4.5% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
ADUSAddus HomeCare Corporation
Medical Care Facilities · $114.33 · beta 0.83
Why now
Medical Care Facilities · market cap $2.1b. 8% off the 52-week high of $124.44. Revenue growing +23%, comfortably above the S&P median. 13 sell-side analysts rate this a Buy with a mean 1-yr target of $134.08 (implying +17% upside).
Moat
FCF converts 147% of net income — earnings translate cleanly into cash.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where GRDN and ADUS diverge
On the headline score the gap is 4.7 points in favor of ADUS. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.
ValueGRDN 48.1 · ADUS 83.6ADUS +35.5
QualityGRDN 81.0 · ADUS 59.1GRDN +21.9
GrowthGRDN 87.2 · ADUS 83.6GRDN +3.6
Pillars run 0–100. Value is judged against each company's own sector, so a Value score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.
Common questions
Is ADUS or GRDN the better stock?
ADUS scores higher: ADUS 74.5, GRDN 69.8 out of 100 on the Bull Rankings quality-growth score, which blends business quality, growth and valuation into one number. A higher score means a stronger business at a more reasonable price — it is not a price target or a recommendation.
Where do ADUS and GRDN differ most?
The widest gap is value, where ADUS leads by 36 points on the 0–100 pillar scale. Neither name sweeps: they trade the lead across the three pillars, so the comparison is a trade-off rather than one being better on every measure.
How are ADUS and GRDN scored?
Each carries the same 0–100 quality-growth score used everywhere on the site, built from three pillars — quality (profitability and returns on capital), growth (revenue and earnings), and value (what you pay for them) — combined as a geometric mean, so a weak pillar cannot be papered over by a strong one.
How current is this comparison?
The whole universe is re-scored every trading day after the US market close, so the scores and fundamentals here reflect the latest published edition.